Literature DB >> 2438331

Transcriptional regulation of genes encoding the acute-phase proteins CRP, SAA, and C3.

G Goldberger, D H Bing, J D Sipe, M Rits, H R Colten.   

Abstract

Inflammation or acute tissue injury results in a programmed change in the concentration of several plasma proteins. Among these proteins, two--C-reactive protein (CRP) and serum amyloid A protein (SAA)--increase up to 1000-fold after an acute-phase stimulus in humans and rabbits. To determine the mechanism for regulation of acute-phase gene expression, we examined changes in the rates of transcription and specific hepatic mRNA content for rabbit CRP, SAA, and some complement protein mRNA during an acute-phase response. Induction of a sterile inflammatory reaction with intramuscular injection of turpentine resulted in an increase in the hepatocellular content of CRP, SAA, C3, and factor B mRNA and the transcription of CRP, SAA, and C3 genes. These data suggest that the increase in CRP, SAA, and C3 serum concentrations observed during an acute-phase reaction is due to an increase in biosynthesis and is, at least in part, under transcriptional control.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438331

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Hepatic acute phase reaction in vivo and in vitro.

Authors:  H Baumann
Journal:  In Vitro Cell Dev Biol       Date:  1989-02

2.  Rat serum amyloid P component. Analysis of cDNA sequence and gene expression.

Authors:  S B Dowton; S D McGrew
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

3.  Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen.

Authors:  L R Hendricks-Taylor; G J Darlington
Journal:  Nucleic Acids Res       Date:  1995-11-25       Impact factor: 16.971

4.  A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6.

Authors:  D R Wilson; T S Juan; M D Wilde; G H Fey; G J Darlington
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

5.  Serum markers of immune activation and liver allograft rejection.

Authors:  E Lalli; R Meliconi; R Conte; A Mancini; M Uguccioni; G F Stefanini; G Gasbarrini
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

6.  Oct-1 acts as a transcriptional repressor on the C-reactive protein promoter.

Authors:  Bhavya Voleti; David J Hammond; Avinash Thirumalai; Alok Agrawal
Journal:  Mol Immunol       Date:  2012-06-29       Impact factor: 4.407

Review 7.  Role of C-Reactive Protein in Diabetic Inflammation.

Authors:  Julijana Stanimirovic; Jelena Radovanovic; Katarina Banjac; Milan Obradovic; Magbubah Essack; Sonja Zafirovic; Zoran Gluvic; Takashi Gojobori; Esma R Isenovic
Journal:  Mediators Inflamm       Date:  2022-05-17       Impact factor: 4.529

8.  Relationship between angiotensinogen, alpha 1-protease inhibitor elastase complex, antithrombin III and C-reactive protein in septic ARDS.

Authors:  U Hilgenfeldt; W Kellermann; G Kienapfel; M Jochum
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter.

Authors:  Prem Prakash Singh; Bhavya Voleti; Alok Agrawal
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

10.  Cellular distribution of nuclear factor kappa B binding activity in rat liver.

Authors:  A R Freedman; R J Sharma; G J Nabel; S G Emerson; G E Griffin
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.